sur HYBRIGENICS (EPA:ALHYG)
Hadrien Lanvin Appointed Deputy CEO of Aton Group
Aton Group has announced the appointment of Hadrien Lanvin as Deputy CEO. A leader in life sciences and medical technology, Aton hopes to leverage Lanvin's extensive expertise to enhance its asset portfolio. Lanvin, an HEC Paris alumnus and CEO of Evora Biosciences, joined Aton's Board of Directors in December 2023. He possesses significant knowledge of the group's portfolio and market dynamics.
In his new executive role, Lanvin aims to maximize the valuation of Aton's assets. He will focus on refining the group's strategic positioning and growth prospects. His responsibilities include boosting Aton's visibility in financial and industrial ecosystems. Chairwoman and CEO Léone Atayi expressed confidence in Lanvin's abilities to drive the company's growth at this critical juncture.
This leadership change aligns with Aton's strategic roadmap and highlights its commitment to transparent communication with the financial community.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de HYBRIGENICS